Antipsychotic drugs are effective for the treatment of schizophrenia. However, the functional consequences and subcellular sites of their accumulation in nervous tissue have remained elusive. Here, we investigated the role of the weak-base antipsychotics haloperidol, chlorpromazine, clozapine, and risperidone in synaptic vesicle recycling. Using multiple live-cell microscopic approaches and electron microscopy of rat hippocampal neurons as well as in vivo microdialysis experiments in chronically treated rats, we demonstrate the accumulation of the antipsychotic drugs in synaptic vesicles and their release upon neuronal activity, leading to a significant increase in extracellular drug concentrations. The secreted drugs exerted an autoinhibitory effect on vesicular exocytosis, which was promoted by the inhibition of voltage-gated sodium channels and depended on the stimulation intensity. Taken together, these results indicate that accumulated antipsychotic drugs recycle with synaptic vesicles and have a use-dependent, autoinhibitory effect on synaptic transmission.
INTRODUCTION
Schizophrenia is a common, chronic, and severe mental disorder in which the brain loses its ability to discern the relevancy and origin of information, leading to misinterpretations, hallucinations, and delusions (Freedman, 2003; Kapur, 2003) . It is believed that schizophrenia is caused by defects in various neurotransmitter systems (Lisman et al., 2008) and the combined action of multiple genetic defects and environmental factors (Harrison and Weinberger, 2005) .
Typical antipsychotic drugs (APDs) such as haloperidol (HAL) and atypical APDs such as risperidone (RSP) and clozapine (CLO) are effective for treating the symptoms of schizophrenia. These drugs share a common action at dopamine (DA) receptors and also affect other neurotransmitter receptors (Lisman et al., 2008; Strange, 2001) . During treatment, APDs accumulate in all brain regions (Gemperle et al., 2003; Kornhuber et al., 1999 Kornhuber et al., , 2006 Korpi et al., 1984; Tsuneizumi et al., 1992) , and it has been hypothesized that the slow development of their full effect coincides with their tissue accumulation. The accumulation of weak-base psychotropic drugs in acidic organelles results from acidic trapping after intraluminal protonation of these weak bases with pKa values near to neutrality (de Duve et al., 1974; Schmalzing, 1988; Trapp et al., 2008) . In addition, membrane potential differences could also drive the accumulation of cationic molecules in electronegative compartments (Duvvuri et al., 2004) . Our current knowledge regarding the role of psychotropic drugs in synaptic vesicle recycling is limited, and the functional consequences of a hypothesized APD accumulation in synaptic vesicles (Rayport and Sulzer, 1995) have remained elusive. In the present study, we clarified the intravesicular accumulation of APDs and its effects on synaptic transmission. We show that the exocytic release of APDs from synaptic vesicles increased extracellular concentrations in freely moving rats and allowed them to inhibit synaptic transmission in a use-dependent manner. This paper describes the release and autoinhibitory action of APDs that accumulated in synaptic vesicles.
RESULTS

Accumulation of APDs in Synaptic Vesicles
The subcellular distribution and accumulation of nonfluorescent APDs can be studied using fluorescent model substances with similar physicochemical properties (Rayport and Sulzer, 1995; Kornhuber et al., 2010) , such as LysoTracker Red (LTR). When assessed by a Fick-Nernst-Planck equation-based model (Trapp et al., 2008) , in which the parameters (such as the cytosolic and organelle diameters and the membrane potential) were adjusted to fit hippocampal synapses and vesicles, the accumulation of LTR was found to be similar to that of the four APDs: chlorpromazine (CPZ), HAL, RSP, and CLO (Table 1) . When parting from therapeutic plasma concentrations, all of the APDs (Baumann et al., 2004) as well as LTR reached micromolar intravesicular concentrations. Incubating hippocampal neuronal cultures with 50 nM LTR resulted in a punctate fluorescence staining. Costaining with pH-dependent aSyt1-cypHer5 antibodies (Adie et al., 2002; Welzel et al., 2011) , specific for the acidic lumen of synaptic vesicles (see Figures S1A-S1D available online), revealed correlated intravesicular fluorescence in synaptic boutons ( Figure S1D ) and brighter uncolocalized staining of other acidic compartments such as lysosomes (Figure 1A; colocalization analysis in Figures S1E and S1F) . Ultrastructural analysis of cultures stained with photoconverted LTR confirmed accumulation in extrasynaptic organelles and synaptic vesicles with FM dye photoconversion-like staining (Figures 1B and S1B) . Because of this low intrasynaptic volume fraction of synaptic vesicles, synaptic boutons were stained less prominently when compared with other acidic organelles. The LTR fluorescence at synaptic loci corresponded to a concentration of 180 nM LTR in solution ( Figure S2 ), which is an underestimate because a synapse's volume comprises only part of the total focal volume. According to our model calculations, the addition of 50 nM LTR should result in an intravesicular concentration of $2.8 mM, which agrees fairly well with the experimentally determined vesicular concentrations of 2.2 mM ( Figure S2B ).
To probe the accumulation of APDs more directly, we next tested the ability of APDs to displace the model substance from synapses. This experimental approach has been used to measure drug accumulation in lysosomes by Kornhuber et al. (2010) and in acidic organelles by Rayport and Sulzer (1995) . As before, hippocampal neurons were incubated with 50 nM LTR and stained with aSyt1-cypHer5 ( Figure 1C) . The fluorescence of LTR-stained organelles decreased after the APD application ( Figure 1E ). Quantification of LTR fluorescence at synaptic sites after APD application revealed a dose-dependent fluorescence decrease ( Figure 1D ) that, in its amplitude, fitted the displacement of LTR from synaptic vesicles. The decrease was not explained by quenching of the dye by the APDs ( Figure 1F ) and was not observed at synapses labeled with the spectrally similar FM4-64 ( Figures 1D and 1F ).
Accumulation of APDs in Synaptic Vesicles Requires an Acidic Intravesicular Environment
The accumulation of APDs is thought to depend mainly on the low pH, but it could also be affected by electrical gradients. In addition to LTR treatment, synapses were labeled with both aSyt1-Oy488 (to quantify number of synaptic vesicles) and aSyt1-cypHer5 as a control for vesicular pH (Figure 2A ). Quantification of the cypHer5 fluorescence signal demonstrated the efficient inhibition of vesicular acidification by 80 nM folimycin (Groemer and Klingauf, 2007; Sankaranarayanan and Ryan, 2001) . Similarly, LTR fluorescence was significantly reduced at an increased intravesicular pH (Figures 2B and 2C) . In contrast, depolarization by increased extracellular K + concentrations ($40mV) had no significant effect on synaptic LTR accumulation.
Results from fluorescence imaging were mirrored by those obtained by model calculations ( Figure 2D ). Given that the synaptic vesicle volume comprises only 5.4% of the synaptic volume and that LTR also accumulates in the cytosol (Table 1) , the LTR signal is predicted to be reduced to 55% over the entire synapse. This matches the experimentally obtained LTR fluorescence of 64.2% in the presence of folimycin reasonably well. We conclude that the accumulation of APDs is a result of the low intravesicular pH.
APD-Induced Displacement of LTR Is Not Due to the Dissipation of Vesicular pH Gradients
The dissipation of vesicular pH gradients by APDs themselves could contribute to the observed loss of LTR signal upon APD application. To test this possibility, we performed experiments with synaptopHluorin (spH), an optical probe consisting of a pH-sensitive GFP coupled to the intravesicular domain of synaptobrevin 2 (Miesenbö ck et al., 1998) . First, we measured the spH fluorescence increase following full deacidification of the recycling pool to the external pH of 7.4 with folimycin. The spH fluorescence increased by 48.6% ± 10.2% (data from Welzel APDs of different classes are weak bases and accumulate in synaptic vesicles as calculated using a cell model adapted from Trapp et al. (2008) . When present in therapeutic plasma concentrations in the extracellular space, the drugs accumulate to intravesicular concentrations in the low micromolar range. K ow , octanol water partition coefficient; pK a , acid dissociation constant; SV, synaptic vesicle; n.a., not applicable.
et al., 2011) in our imaging setup. This dissipation of the vesicular pH gradients was in accordance with the previously mentioned reduction of LTR fluorescence by folimycin ( Figures 2B and 2C ). Accordingly, if the LTR fluorescence loss of, e.g., $30% upon application of HAL 5 mM (Figure 2 ) was from the dissipation of vesicular pH gradients, then applying the drug would need to increase the intravesicular spH fluorescence comparably to folimycin. However, upon APD application only marginal differences in the spH fluorescence were observable, which were at the detection limit of our camera system ( Figures 2E, 2F , and S3). The spH fluorescence, however, was very sensitive to small NH 4 Cl-induced changes of the intravesicular pH ( Figure 2E) . Thus, the dissipation of the vesicular pH gradient by APDs in the concentrations used here is not a major factor contributing to the loss of LTR fluorescence.
APDs Are Released from Synaptic Vesicles via Exocytosis Next, we tested whether accumulated weak bases can be released from synaptic vesicles via exocytosis. Hippocampal neurons stained with LTR and aSyt1-cypHer5 were electrically stimulated with varying intensities (600 action potential-like pulses [APs] at 30 Hz, 200 APs at 10 Hz, no Ca 2+ ; Figure 3A) . We found that, as suggested previously by Schmalzing (1988) , electrical stimulation led to a decrease in the LTR fluorescence at the synaptic sites, which depended on the presence of Ca 2+ and increased with the strength of the stimulus ( Figure 3B ). The Ca 2+ dependence, together with the fact that moderately depolarizing the cells with increased extracellular K + concentration did not significantly affect the accumulation of LTR in synaptic vesicles (Figure 1 ), argues against a passive LTR release resulting from the disruption of the electrical gradient across the synaptic membrane. Moreover, the different amounts of dye that were lost in response to varying stimulation intensities fit the expectations of vesicular exocytosis ( Figure 3C ). Importantly, intense LTR signals that did not colocalize with the synapse marker synaptotagmin1 and might stain lysosomes or other acidic cellular organelles did not show a decrease in fluorescence upon electrical stimulation ( Figure 3D ), again arguing for the release of LTR from synaptic vesicles via Ca 2+ -dependent exocytosis.
Activity-Dependent HAL and Transmitter Release in Freely Moving Animals
To assess APD release after chronic treatment in vivo, we performed microdialysis in freely moving rats, which was followed by quantification of neurotransmitter and HAL. Animals were implanted with osmotic minipumps, which delivered HAL (0.5 mg/kg/d) for 14 days (Samaha et al., 2007) , a dose that was shown to provide a brain DA D2 receptor occupancy similar to that required for human antipsychotic treatment action . On day 14, triple-probe microdialysis was performed, measuring extracellular levels of HAL in the prefrontal Figure S1 .
cortex (PFC) and the dorsal striatum (DStr) and extracellular levels of DA and serotonin (5-HT) in the nucleus accumbens (NAc), as a reference for transmitter release ( Figure 3E ) (Amato et al., 2011) . Baseline levels of HAL were 143.9 + 28.4 pg/ml in the PFC and 179.1 + 40.5 pg/ml in the DStr (n = 5), which was not corrected for recovery (in vitro, 84.7%). A 100 mM K + challenge, applied locally by reverse dialysis (Chen and Kandasamy, 1996) , significantly increased the extracellular HAL concentrations compared to the baseline in the PFC (40 min samples, samples S3 and S4 versus baseline; p < 0.05) and DStr (40 min samples, samples S3 and S4, versus baseline; p < 0.05) during the K + challenge ( Figure 3F ). This was paralleled by an increase in extracellular DA (20 min samples, samples S5-S8, versus baseline; p < 0.05) and 5-HT levels (20 min samples, samples S5 and S6, versus baseline; p < 0.05) ( Figure 3G ). These data suggest that the extracellular HAL concentration in the brain is activity dependent after chronic HAL treatment in freely moving animals. It behaves similarly to the neurotransmitters DA and 5-HT. The different amounts of secreted HAL might reflect varying accumulation, release, or even receptor distribution properties, depending on the brain region. The activity-dependent increase of HAL concentrations in the dialysate from the synaptic cleft supports the idea of transient high APD concentrations, especially in close proximity to the vesicle fusion sites after synaptic vesicle fusion and APD release. It should be noted that the absolute values reported here must be evaluated cautiously, while the increases, in general, fit well with the findings in primary cultures.
APDs Inhibit Synaptic Vesicle Exocytosis
To analyze the functional consequences of APD application on synaptic vesicle recycling, we used rat hippocampal neurons transfected with spH, an established reporter of exo-and endocytosis ( Figure 4A ) (Sankaranarayanan et al., 2000) . Our experimental setup consisted of 18 electrical stimulations with 50 AP (10 Hz) every 1.5 min. During min 6-18 of the experiment, the cells were perfused with either APDs or vehicle ( Figure 4B ). We observed dose-dependent reductions of the evoked exocytosis fluorescence responses upon administration of APDs in contrast to vehicle control ( Figure 4C ). This reduction was reversible for all four APDs. Compensatory endocytosis of synaptic vesicles was not affected by HAL, CPZ, CLO, and RSP ( Figure S4 ). We conclude that APDs inhibit electrically stimulated synaptic vesicle exocytosis in a dose-dependent manner.
APDs Reduce Presynaptic Calcium Transients
Action potential propagation along the axon results in the influx of Ca 2+ through voltage-gated ion channels into synaptic boutons, which triggers fast synaptic vesicle exocytosis. Because APDs have been described to have diverse effects on the ion channels involved in this process (Ogata et al., 1989; Sah and Bean, 1994; Wakamori et al., 1989; Yang and Wang, 2005) , we next tested whether the observed inhibition of exocytosis is directly linked to ion channel modulation or is the result of effects on the multitude of proteins involved in the assembly and function of the presynaptic vesicle release machinery itself. We first analyzed the role of calcium channels because Ca 2+ is directly linked to vesicle release via the Ca 2+ -sensor synaptotagmin. We measured stimulation-dependent changes in fluo-4-fluorescence while blocking postsynaptic Ca 2+ influx by AP5 (Koester and Johnston, 2005; Oertner et al., 2002; Schiller et al., 1998) . Fluo-4 showed a strong fluorescence increase upon electrical stimulation and Ca 2+ influx ( Figure 5A ) (Gee et al., 2000) . Synaptic boutons were identified by their activitydependent FM styryl dye uptake and release (Groemer and Klingauf, 2007) , and fluo-4 fluorescence was quantified in these regions ( Figure 5A ). Similar to the spH experiments (Figure 4) , the vehicle control did not alter the presynaptic Ca 2+ influx evoked by subsequent trains of 50 AP, whereas CPZ, HAL, CLO, and RSP significantly reduced the Ca 2+ influx ( Figures   5B-5D ). This inhibition of Ca 2+ influx was reversible upon drug washout for all of the APDs ( Figures 5C and 5D ). When comparing the APD-induced amplitude reductions in the evoked fluo-4 and spH fluorescence increases, we found a strong positive correlation ( Figure 5E ) (R = 0.86; p < 0.001) between the two parameters. Thus, the inhibition of presynaptic Ca 2+ influx correlated strongly with the inhibition of synaptic vesicle exocytosis for all of the APDs. Although this result allowed us to conclude that no molecular target within the synaptic vesicle release machinery is involved in the mediation of the APD effect, the reduced Ca 2+ influx is not sufficient evidence to conclude that calcium channels are a direct target of APDs.
Presynaptic Inhibition of Synaptic Transmission by APDs Is a Result of Sodium Channel Inhibition
Upstream of the Ca 2+ influx, an APD effect on sodium channels might be responsible for the reduced neurotransmitter release via exocytosis. This would fit well with previous reports about their modulation by APDs (Ogata et al., 1989) . Thus, we first designed optical experiments to analyze the contribution of sodium channel inhibition by the APDs on vesicle exocytosis. Hippocampal neurons were stimulated either electrically with 200 AP, 10 Hz, or chemically with 40 mM K + , 20 s, and 1 mM TTX ( Figure 6A ), which can evoke exocytosis by directly depolarizing the presynaptic terminals in an action potentialindependent manner. Both of the stimulation paradigms led to a marked increase in spH fluorescence with comparable amplitudes. An application of the sodium channel blocker TTX (1 mM) almost completely diminished the signal that was evoked by electrical stimulation ( Figure 6B ). If sodium channels were involved in the inhibition of vesicular exocytosis by APDs, then the exocytosis signal from a high potassium application should not be depressed by APDs. Indeed, the spH amplitude in response to a high potassium application was not significantly reduced upon application of 5 mM HAL ( Figure 6B ), which points to voltage-gated sodium channels as the primary presynaptic target for APD action.
State-and Use-Dependent Inhibition of Sodium Channels by HAL We next performed experiments with N1E115 neuroblastoma cells, which generate an endogenous sodium current mediated by TTX-sensitive Na v 1.1 and Na v 1.2 sodium channels. We transfected the N1E115 cells with a TTX-resistant Na v 1.6 mutant and recorded sodium currents during the application of HAL (0.25-125 mM). By adding TTX to the bathing solution, we could distinguish the effects of HAL on the endogenous current mediated by Na v 1.1 and Na v 1.2 from current solely carried by Na v 1.6. Axons in the central nervous system have been shown to express all three voltage-dependent sodium channel isoforms studied here, with a clear preponderance of Na v 1.2 and Na v 1.6 (Lorincz and Nusser, 2008) . Because the activation threshold of Na v 1.6 is considerably lower than that of Na v 1.2, . The chemically induced exocytosis was insensitive to TTX and HAL application. ***p < 0.001; n.s., not significant; t tests. (C) Dose-response curves for HAL block of endogenous (Na v 1.1/Na v 1.2) and Na v 1.6r current in N1E115 neuroblastoma cells were determined from steady-state recordings using the activation protocol depicted as inset (V h À90mV).
(D) Steady-state activation curves were constructed from the activation protocol of (A) and the inactivation protocol (depicted as an inset) before and during the application of HAL (25 mM). Data points were fitted with the use of a Boltzmann equation. Half-activation potential V mid was À13.8 ± 1.4mV (Na v 1.6r), À13.6 ± 1.0mV (Na v 1.6r plus HAL), À8.9 ± 1.1mV (Na v 1.1/Na v 1.2), and À10.7 ± 1.0mV (Na v 1.1/Na v 1.2 plus HAL), with p = 0.004 for control versus 25 mM HAL in Na v 1.1/Na v 1.2. Half-inactivation potential V mid was À61.4 ± 1.1mV (Na v 1.6r), À79.3 ± 1.4mV (Na v 1.6r plus HAL), À61.9 ± 1.7mV (Na v 1.1/Na v 1.2), and À72.6 ± 2.2mV (Na v 1.1/Na v 1.2 plus HAL), with p = 8.9E-6 for control versus 25 mM HAL for Na v 1.6r and p = 1.0E-5 for control versus 25 mM HAL for Na v 1.1/Na v 1.2. There was p = 0.002 for a HAL-induced voltage shift of Na v 1.6r versus Na v 1.1/Na v 1.2 (n = 8 for Na v 1.6r, n = 7 for Na v 1.1/Na v 1.2). (E) A gradual recovery from inactivation in a double-pulse protocol with an increasing interpulse interval (inset) is shown here for the endogenous current under the control conditions. The test pulse duration was 5 ms. The intervals between test pulses (Dt) are denoted above the peak of the second current response. (F) Plot summarizing the effect of HAL (25 mM) on the recovery from inactivation. The peak current elicited by the second pulse was normalized to the peak current of the first pulse. The data points were fitted using a biexponential function and were plotted against the interpulse interval. Here, n = 3 for Na v 1.6r and n = 3 for Na v 1.1/Na v 1.2, at 20 ms. Additionally, p = 0.029 for control versus 25 mM HAL for Na v 1.1/Na v 1.2, and p = 0.04 for control versus 25 mM HAL for Na v 1.6r. Na v 1.6 was assigned the role of axonal ''detonator,'' triggering impulse generation and conduction (Hu et al., 2009; Royeck et al., 2008) .
In the first set of experiments, we determined dose-response relationships for the inhibitory action of HAL on the endogenous sodium current and Na v 1.6 using a standard activation protocol ( Figure 6C, inset) . From the dose-response curves depicted in Figure 6C , we calculated that half-maximal inhibition (IC 50 ) of the peak sodium current occurred at 13.1 ± 2.1 mM and 10.2 ± 4.0 mM for Na v 1.1/Na v 1.2 and Na v 1.6, respectively. We then examined the effect of 25 mM HAL on their steady-state activation and inactivation. HAL produced a small but significant leftward shift of the activation curve of the endogenous sodium current, whereas Na v 1.6 activation remained unaffected. In contrast, HAL produced a much more pronounced shift of steady-state inactivation to more negative potentials for both endogenous current and Na v 1.6 ( Figure 6D ). The leftward shift of inactivation strongly suggested a preferential binding of HAL to inactivated sodium channels. We calculated (see Supplemental Experimental Procedures) K i values to be 1.5 mM for Na v 1.1/Na v 1.2 and 0.18 mM for Na V 1.6. These findings indicate that HAL shows a pronounced state-dependent binding, with its affinity to the inactivated state one (Na v 1.1/ Na v 1.2) or even two orders of magnitude (Na v 1.6) higher than to the resting state. The preferential binding of HAL to inactivated Na v 1.6 is of particular functional significance, given the pivotal role of this Na v isoform in controlling the axonal excitability.
We next investigated the use dependence of the HAL block by measuring the gradual recovery of the peak sodium current from inactivation in a double-pulse protocol, in which the interpulse interval was increased stepwise ( Figure 6E ). Under control conditions, endogenous currents and Na v 1.6 completely recovered within approximately 20 ms. In the presence of HAL (25 mM), however, both currents exhibited a slower and incomplete recovery ( Figure 6F ). Together, our data indicate that HAL inhibits high-threshold as well as low-threshold sodium channels of central nervous system axons in a highly state-and usedependent fashion at concentrations that are well within the therapeutic range.
The Degree of Inhibition of Synaptic Vesicle Exocytosis Is Stimulation Dependent
The use-dependent inhibition of sodium channels should result in a use-dependent inhibition of synaptic vesicle exocytosis. To test this hypothesis, we quantified the inhibition of exocytosis with HAL under weak (60 AP, 40 Hz) and more intense (180 AP, 40Hz) stimulation conditions by monitoring the spH fluorescence response of cultured hippocampal neurons to two identical electrical stimulations 5 min apart. The second stimulus was applied in the presence of the drug or vehicle ( Figure 7A) . Indeed, increasing the number of APs from 60 to 180 significantly increased the relative inhibition of exocytosis by 5 mM HAL and enabled 0.5 mM HAL to significantly inhibit exocytosis ( Figure 7B ).
To provide further evidence for an activity-dependent inhibition of exocytosis in the context of preserved neuronal networks, we performed electrophysiological whole-cell recordings from visually identified neurons in hippocampal and NAc slices. Functional consequences of a use-dependent sodium channel inhibition were assessed by applying stimulus trains. Excitatory postsynaptic currents (EPSCs) of hippocampal CA1 pyramidal neurons were measured during a 25 Hz stimulus train of 4 s duration in the absence and presence of two concentrations of HAL (0.5 and 5 mM). Under control conditions, the stimulus train produced an initial increase of the EPSC amplitude, which slowly decayed and approached baseline toward the end of the train (Figures 7C and 7D) . The initial rise was also observed in HAL, but EPSCs declined soon below baseline in a dose-dependent fashion ( Figures 7C and 7D) . The progressive reduction of EPSCs during the train reflects the use dependence of the APD effect and is in line with the fluorescence measurements presented in Figure 7B .
We used two strategies to substantiate our concept that the use-dependent inhibition of EPSC is causally linked to the blockade of voltage-gated sodium channels ( Figure 6 ). First, we demonstrated that the effects of HAL on train-evoked EPSCs could be mimicked by a low concentration of the highly potent and selective sodium channel blocker TTX (25 nM, Figures 7C  and 7D ). Second, we functionally isolated axonal action potentials and recorded their extracellular equivalent, the so-called fiber volleys (FVs), in the absence and presence of either a low concentration of TTX or several APDs. Under control conditions, FVs exhibited only a small decrement later in the train. In sharp contrast, TTX, which is known to block sodium channels in a use-dependent manner (Conti et al., 1996) as well as all of the three APDs tested (5 mM HAL, 30 mM CPZ, 30 mM RSP), produced a pronounced use-dependent inhibition of FVs (Figure 7E) . The depressant effect of APDs on EPSCs during train stimulation is, therefore, sufficiently explained by their inhibitory action on axonal action potentials.
Notably, the effect was not limited to the hippocampus but was also observed in the NAc, which is a major target region of dopaminergic projections and contains mainly medium spiny neurons expressing D1 or D2 DA receptors. The behavior of EPSCs in NAc medium spiny interneurons during stimulus trains was remarkably different from that in hippocampal CA1 pyramidal cells because, even under control conditions, EPSCs displayed only a brief and weak initial enhancement before they progressively decayed ( Figures 7F and 7G) . As a consequence, the inhibitory effect of HAL (5 mM) was much more pronounced when compared to the hippocampus ( Figures 7F and 7G) . Importantly, FVs in NAc proved to be approximately equally resistant to stimulus trains compared with hippocampal FVs, and HAL reduced FVs with similar efficacy ( Figure 7H ). These data indicate that, in the NAc with its dense dopaminergic innervation, transmitter release is especially sensitive to the use-dependent inhibition of axonal sodium channels by APDs.
Effective Inhibition of Exocytosis Requires the Accumulation of APDs in Synaptic Vesicles
To determine whether the accumulation of APDs in synaptic vesicles is required for the efficient inhibition of exocytosis, we assessed the extent of the inhibition induced by 5 mM HAL in the presence of folimycin, which abolished the accumulation of HAL in synaptic vesicles (Figure 1) . Exocytosis was measured with FM4-64 ( Figure 8A ). The fluorescence of the dye was unaffected by changes of the intravesicular pH value ( Figure 2B ) or by APD administration ( Figure 2D ). As expected, 5 mM HAL inhibited the FM4-64 release that occurred in response to stimulation with 600 AP at 30 Hz (Figures 8B and 8C) . However, in the presence The ratio of spH fluorescence increases before and after the administration of HAL (0.5 or 5 mM), which was evoked with either 60 or 180 action potentials (AP) at 40 Hz (n = 3 to 6, n > 120). Error bars represent SEM. *p < 0.05, **p < 0.01, n.s. not significant, t tests. (C and D) The incubation of hippocampal slices with HAL (0.5 and 5 mM) for 2-5 hr dramatically enhanced the use-dependent reduction of EPSC amplitudes (vehicle, n = 5; HAL 0.5 mM, n = 6; HAL 5 mM, n = 5) during 100 stimuli at 25 Hz. This effect was mimicked by low-dose TTX (25 nM, 2-4 hr incubation, n = 5). EPSCs were normalized to their amplitudes before the train. Illustrations in (C) are typical traces from different experiments. Insets depict superimposed EPSCs before and 2 s after the start of a 25 Hz train with and without HAL incubation. (E) Incubation of hippocampal slices (for 2-5 hr) with HAL (5 mM, n = 7), CPZ (30 mM, n = 5), RSP (30 mM, n = 5), and TTX (25 nM, n = 5) reduced CA1 axonal activity during a 25 Hz train (vehicle n = 11). CA1 FVs were normalized to their amplitudes before the train. Insets depict superimposed FVs before and 2 s after the start of a 25 Hz train. (F and G) Incubation of slices containing NAc with HAL (5 mM) for 2-6 hr dramatically enhanced the use-dependent inhibition of EPSCs (vehicle, n = 8; HAL 5 mM, n = 7) during 100 stimuli at 25 Hz. Insets depict superimposed EPSCs before and 1 s after the start of a 25 Hz train with and without HAL incubation. (H) Incubation of NAc slices with HAL (5 mM) for 2-6 hr reduced axonal activity (vehicle, n = 6; HAL 5 mM, n = 6) during 100 stimuli at 25 Hz. Insets depict superimposed FVs before and 1 s after the start of a 25 Hz train. of folimycin, the inhibition of exocytosis by HAL was significantly (p < 0.05) reduced, while the administration of folimycin alone did not affect exocytosis ( Figure S5 ; Sankaranarayanan and Ryan, 2001) .
To measure this effect with another pH-independent optical probe, we repeated the experiment with the Ca 2+ -sensitive dye fluo-4 ( Figure 8D ). Again, electrical stimulation resulted in a marked increase in fluo-4 fluorescence, which was reduced upon HAL (5 mM) application ( Figure 8E ). In agreement with the FM experiments described in the previous paragraph, folimycin application significantly decreased the reduction of the fluo-4 amplitude induced by HAL ( Figure 8F) . Thus, the accumulation of APDs in synaptic vesicles significantly contributes to their inhibitory effects on synaptic vesicle exocytosis.
DISCUSSION
During treatment, APDs and other psychotropic drugs accumulate in the brains of patients. In the present work, we studied the subcellular localization of APD accumulation in acidic organelles and identified functional consequences of this phenomenon. We demonstrated that accumulated APDs are secreted from synaptic vesicles upon exocytosis, leading to increased extracellular drug concentrations during neuronal activity. The secretion of APDs in turn was able to inhibit synaptic transmission in a use-dependent manner.
Increase of Extracellular Concentrations by Activity-Dependent Secretion of APDs
We found that synaptic transmission as measured by synaptic vesicle exocytosis was reduced by APDs in low micromolar concentrations. This concentration range raised our concerns because it has been convincingly demonstrated that the clinical efficacy of APDs correlates with effects observed for nanomolar concentrations (Seeman et al., 1976) . Additionally, APDs acutely inhibit sodium channels in low micromolar concentrations (Figure 6 ), which in previous work were found unlikely to be achieved extracellularly during APD therapy (Baumann et al., 2004) . Thus, instead of therapeutic benefits, continuously present micromolar APD concentrations were related mainly to side effects of the drugs (Ogata et al., 1989) .
A major part of our study was, therefore, devoted to demonstrate that the accumulation of APDs in synaptic vesicles (Table  1 ; Figures 1 and 2 ) results in high APD concentrations within these confined compartments. Upon activity, synapses release their micromolar APD content into the synaptic cleft (Figure 3) . We confirmed the activity-dependent release by in vitro fluorescence microscopy and in vivo data from experiments with freely moving rats treated with HAL. The released APDs have an inhibitory effect on signal propagation by promoting sodium channel inactivation (Figures 6 and 7) . Even the extracellular HAL concentrations in the nanomolar range were sufficient to exert a use-dependent inhibitory action under prolonged stimulation (Figures 6 and 7) . Accordingly, APD concentrations inhibiting sodium channels are likely to be reached at least locally during neuronal activity. Overall, both inhibition of sodium channels and activity-dependent secretion contribute to the use-dependent action of the drugs. The present work, thus, suggests a mechanism wherein the presence of APDs in synaptic vesicles results in increased extracellular APD concentrations upon neuronal activity, leading to autoinhibitory feedback on synaptic transmission.
Potential Implications of APD Accumulation and Secretion Affecting the Understanding of Therapeutic Actions of APDs While the therapeutic effect of APDs starts soon after application, it usually reaches its maximum after 4-6 weeks (Agid et al., 2003; Leucht et al., 2005) . The effects on synaptic transmission reported here, which are based on the accumulation of the drugs, might contribute to the slow development of the full therapeutic action of the drugs because tissue accumulation occurs within the same time range (Kornhuber et al., 1999) . Accordingly, accumulation and secretion effects could explain the beneficial effects of electroconvulsive therapy (ECT) during APD treatment, which are not observed when ECT is performed without APD therapy (Falkai et al., 2005) . In light of our findings (Figures 3 and 4) , the concentration of APDs available locally is likely to be increased acutely upon ECT-induced seizures.
Physiologically, precisely mediated negative feedback inhibition of neocortical pyramidal cells is necessary for the generation of synchronized high-frequency oscillations, which are related to attention and perception, and whose disturbance has been linked to the pathophysiology of schizophrenia (Uhlhaas and Singer, 2010) . Such a deficit in synchronization has, for example, been found in psychotic patients prior to antipsychotic treatment (Gallinat et al., 2004) and chronically ill patients (Ferrarelli et al., 2010; Uhlhaas et al., 2006) .
The autoinhibition of synaptic transmission described here by the secretion of accumulated APDs could be beneficial to the generation of synchronized neuronal oscillations in schizophrenia. Our data underline the importance of measuring the neuronal oscillation patterns of unmedicated patients, or patients free of symptoms after sufficient antipsychotic therapy and in an already accumulated drug state. If the secretion of APDs and the associated selective modulation of synaptic transmission were important for the treatment of schizophrenia, then one could further speculate that an enriched environment (Oshima et al., 2003; Tost and Meyer-Lindenberg, 2012 ) is useful for patients under medication, whereas it would harm the psychotic, not yet treated patient.
Concluding Remarks
Taken together, our study proves the concept of APD accumulation first suggested by Rayport and Sulzer (1995) and defines synaptic vesicles as organelles that exert accumulation-and use-dependent inhibitory functional effects. Although we found more pronounced inhibitory effects of APDs in striatal tissue (Figure 7) , which hosts the receptors that bind the drugs in nanomolar concentrations (in this case DA receptors), our current results are limited with respect to other substance classes or synapse types. It will therefore be interesting to investigate the autoinhibitory effects of psychotropic drugs accumulated in synaptic vesicles on specific network activity profiles within cortical (Goto et al., 2010) and subcortical (Kellendonk, 2009) pathways as well as various neurotransmitter systems (Lisman et al., 2008) , especially DA signaling, and differential effects of other classes of psychotropic drugs (Sulzer, 2011) .
EXPERIMENTAL PROCEDURES Ethics Statement
All animal work was approved by the Kollegiales Leitungsgremium of the Franz-Penzoldt Zentrum, Erlangen and was conducted in conformity with the Animal Protection Law of the Federal Republic of Germany and the guidelines of the State of Bavaria.
Cell Culture and Transfection
Hippocampal neuronal cultures were prepared from 1-to 4-day-old Wistar rats. Briefly, newborn rats were sacrificed by decapitation. The hippocampus was removed from each brain and was transferred into ice-cold Hank's salt solution, and the dentate gyrus was cut away. After digestion with trypsin (5 mg ml À1 ), cells were triturated mechanically and plated in MEM, supplemented with 10% fetal calf serum and 2% B27 Supplement (all from Invitrogen, Taufkirchen, Germany). If required, neurons were transfected on DIV3 (days in vitro) with spH (Sankaranarayanan et al., 2000) under the control of a synapsin promoter with a modified calcium phosphate method by Threadgill et al. (1997) . Experiments were performed between DIV25 and DIV30. N1E115 neuroblastoma cells were maintained at 37 C in 5% CO 2 in DMEM (Invitrogen) with 5 g/l glucose and were supplemented with 10% fetal bovine serum (Biochrom, Berlin) and 1% penicillin/streptomycin solution (Biochrom). Cells were trypsinized and plated in 3.5 cm dishes (Corning, Lowell, MA, USA). For recordings from Na V 1.6r, N1E115 cells were transfected on the next day with 1 mg of cDNA for each dish and 0.5 mg of pEGFP-C1 (Mountain View, CA, USA) with Nanofectin (PAA, Pasching, Austria) according to the manufacturers' protocol. The mNa V 1.6 was a gift from E. Leipold and S. Heinemann (Leipold et al., 2006) . The TTX-resistant variant mNaV1.6r Y371S was constructed with the use of the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA, USA).
Imaging
Experiments were conducted at room temperature on a Nikon TI-Eclipse inverted microscope (603, 1.2 NA water-immersion objective; Perfect Focus System). Fluorescence was excited by a Nikon Intensilight C-HGFI through excitation filters centered at 482, 561, and 628 nm using dichroic long-pass mirrors (cutoff wavelength 500, 570, and 660 nm, respectively). The emitted light passed emission band-pass filters ranging from 500 to 550 nm, 570 to 640 nm, and 660 to 730 nm (Semrock, Rochester, NY, USA) and was projected onto a cooled EM-CCD camera (iXonEM DU-885 or iXonEM DU-897; Andor). Coverslips were placed into a perfusion chamber. Please see the Supplemental Experimental Procedures for a description of solutions, dyes, antibodies, and inhibitors for the individual experiments. Throughout the experiments, perfusion was kept constantly at 0.2 ml/min (Fast-Step Valve Control Perfusion System VC-77SP8; Warner Instruments). Fast solution exchanges were achieved by a piezo-controlled stepper device (SF-77B; Warner Instruments) using a three-barrel glass tubing. Synaptic boutons were stimulated by electric field stimulation (platinum electrodes, 10 mm spacing, 1 ms pulses of 50 mA and alternating polarity).
Recorded image stacks were used to automatically detect spots of synaptic bouton size (Sbalzarini and Koumoutsakos, 2005) , where an electrically evoked fluorescence increase (spH and fluo-4) or decrease (FM dyes) occurred in difference images. For LTR DND-99 (Invitrogen, Karlsruhe) experiments, synapses labeled with an anti-Synaptotagmin1 antibody were detected by a Laplace-operator-based peak detection method by Dorostkar et al. (2010) . All image and data analysis was performed using custom-written routines in MATLAB (The MathWorks, Natick, MA, USA). SpH and fluo-4 fluorescence was normalized to the mean stimulation-dependent difference in fluorescence (DF) before drug application.
Photoconversion and Electron Microscopy
Rat hippocampal neurons were incubated with 500 nM LTR for 1 hr at 37 C and subsequently fixed in 2.5% glutaraldehyde in PBS. Illumination for the photoconversion of LTR was performed through a 203 0.5 NA objective (Olympus, Hamburg, Germany) with green light (550 nm) for 45-60 min in the presence of a 1.5 mg/ml DAB solution. Photoconversion of FM1-43 and further electron microscope processing followed a standard protocol by Denker et al. (2009) .
Electrophysiology
Transverse slices containing hippocampus and coronal slices containing NAc (350 mm thick) were prepared from 1-month-old rats. Electrophysiological signals were filtered at 1 kHz and sampled at 10 kHz using a MultiClamp 700B amplifier in conjunction with a Digidata 1440A interface and pClamp10 software (all from Molecular Devices, Sunnyvale, CA, USA). Whole-cell recordings of visualized CA1 pyramidal cells and NAc medium spiny neurons were performed in artificial cerebrospinal fluid (aCSF, see Supplemental Experimental Procedures). Patch pipettes were filled with 135 mM K-gluconate, 5 mM HEPES, 3 mM MgCl 2 , 5 mM EGTA, 2 mM Na 2 ATP, 0.3 mM NaGTP, and 4 mM NaCl (pH 7.3). Constant current pulses (pulse width 0.1 ms, 60-400 mA) were delivered to a concentric bipolar tungsten-stimulating electrode positioned in CA1 stratum radiatum and in NAc to evoke synaptic currents in pyramidal cells and NAc neurons, respectively. Glutamatergic EPSCs were recorded at À80mV (after correcting liquid junction potentials) and were pharmacologically isolated by perfusing slices with picrotoxin (100 mM), APV (50 mM), and CGP 55845 (2 mM). Field potentials arising from axonal action potentials (FVs) were evoked by a bipolar electrode (pulse width 0.1 ms) and were recorded in CA1 stratum radiatum or NAc with extracellular recording pipettes filled with modified aCSF (in which bicarbonate was replaced with HEPES to avoid a pH change). Synaptic responses were abrogated by a combination of low-calcium aCSF (0.5 mM CaCl 2 , 3.5 mM MgCl 2 ), picrotoxin, and the ionotropic glutamate receptor antagonist kynurenic acid (2 mM).
In neuroblastoma N1E115 cells transfected with a TTX-resistant Na v 1.6, sodium currents carried by the TTX-resistant Na v 1.6r mutant were isolated by adding 1 mM TTX (Biotrend, Wangen/Zurich, Switzerland) to the bath. Current signals were recorded in whole-cell voltage-clamp mode at room temperature (21 C ± 1 C). Recordings were sampled at 20 kHz (low-pass filter 5 kHz) using an Axopatch 200A amplifier in conjunction with a Digidata 1322A interface and pClamp10 software. For details on the measurement protocols and the solutions used, please refer to the Supplemental Experimental Procedures.
Microdialysis
Guide cannulae (MAB6.14, Microbiotech) were implanted into male SpragueDawley rats targeting the medial PFC, caudate-putamen, and NAc, as described in Pum et al. (2008) . After 5-6 days of recovery, osmotic minipumps (Samaha et al., 2007) were implanted and used to deliver HAL (0.5 mg/kg/d; i.p.) over a period of 14 days. During the experiments a 100 mM K + challenge was applied for 80 min by reverse dialysis, before the perfusion medium was changed back to aCSF. HAL analysis was performed by LC-MS/MS with online extraction. DA and 5-HT analysis was performed by high-performance liquid chromatography with electrochemical detection (Pum et al., 2008) .
Cell Model of APD Accumulation
The accumulation of APDs in synaptic vesicles was assessed using a mathematical model based on the Fick-Nernst-Planck equation (Trapp et al., 2008 ) (Zhang et al., 2010) , as described in detail in the Supplemental Experimental Procedures. Properties of the test compounds given in Table 1 were estimated using ACD (ACD/LogD Suite version 10.04, 2007; Advanced Chemistry Development, Toronto), and therapeutic plasma levels for CPZ, HAL, CLO, and RSP were taken from Baumann et al. (2004) .
Statistical Analysis
Statistical analysis was performed using MATLAB. Error bars indicate SEM unless otherwise indicated. To analyze the effects of treatment, ANOVA was used. For single-group comparisons, unpaired t tests were applied. These tests were performed using built-in routines in MATLAB.
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